Readily available dental mouthwashes have the potential to destroy the lipid envelope of all coronaviruses, combating virus replication in the mouth and throat.
The findings are presented in a new review article published today in Function, concluding that there is an urgent need to test the effectiveness of this approach in clinical trials.
“Emerging studies increasingly demonstrate the importance of the throat and salivary glands as sites of virus replication and transmission in early COVID-19 disease. SARS-CoV-2 is an enveloped virus, characterised by an outer lipid membrane derived from the host cell from which it buds. While it is highly sensitive to agents that disrupt lipid bio-membranes, there has been no discussion about the potential role of oral rinsing in preventing transmission,” the research team wrote.
“Here, we review known mechanisms of viral lipid membrane disruption by widely available dental mouthwash components that include ethanol, chlorhexidine, cetylpyridinium chloride, hydrogen peroxide and povidone-iodine. We also assess existing formulations for their potential ability to disrupt the SARS-CoV-2 lipid envelope, based on their concentrations of these agents, and conclude that several deserve clinical evaluation.”
Notably, the lipid envelope does not vary when viruses mutate. This means that if the strategy is deemed effective, it should still work against any new coronavirus strains that emerge.
A multidisciplinary international team of scientists and clinicians led by researchers at the Cardiff University School of Medicine co-authored the Evidence Review, while industry partners provided global formulation information.
This article is the 1st of a new style review article, with conclusions entirely based on precisely referenced original peer-reviewed articles. This is an important feature of Function, the newest publication in the American Physiological Society’s family of journals.
Function provides a high-caliber, broad-spectrum open access platform for researchers to publish their major advances in basic, translational and clinical sciences.
From organelles to organisms, Function seeks papers that contribute to defining the mechanistic basis of living systems in health and disease.
Published by the American Physiological Society (APS), Function aims to publish ground-breaking research that extends physiological understanding of biological function and the changes associated with disease states. The journal launched in 2020 and is now accepting submissions.
Physiology is the study of how molecules, cells, tissues and organs function in health and disease.
Established in Y 1887, the American Physiological Society (APS) was the 1st US society in the biomedical sciences field. The Society represents 9,000 members and publishes 16 peer-reviewed journals with a worldwide readership.
Have a healthy day, Keep the Faith!